These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 19022325

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A, Akula KK, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):835-43. PubMed ID: 18234412
    [Abstract] [Full Text] [Related]

  • 7. Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.
    Kumar P, Kalonia H, Kumar A.
    J Psychopharmacol; 2011 Oct 01; 25(10):1399-411. PubMed ID: 20305041
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.
    Kalonia H, Kumar P, Nehru B, Kumar A.
    Indian J Exp Biol; 2009 Nov 01; 47(11):880-92. PubMed ID: 20099461
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats.
    Kalonia H, Kumar P, Kumar A, Nehru B.
    Neurotoxicology; 2010 Mar 01; 31(2):195-203. PubMed ID: 20043943
    [Abstract] [Full Text] [Related]

  • 11. N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.
    Sandhir R, Sood A, Mehrotra A, Kamboj SS.
    Neurodegener Dis; 2012 Mar 01; 9(3):145-57. PubMed ID: 22327485
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
    Colle D, Hartwig JM, Soares FA, Farina M.
    Brain Res Bull; 2012 Mar 10; 87(4-5):397-405. PubMed ID: 22245028
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
    Kalonia H, Kumar P, Kumar A.
    Pharmacol Biochem Behav; 2010 Aug 10; 96(2):115-24. PubMed ID: 20450929
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
    Bhateja DK, Dhull DK, Gill A, Sidhu A, Sharma S, Reddy BV, Padi SS.
    Eur J Pharmacol; 2012 Jan 05; 674(1):33-43. PubMed ID: 22056833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.